Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More
The wiggly targets known to scientists as “intrinsically disordered proteins” have for decades eluded capture by custom-made drugs and antibodies.… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
